Daniel-Adriano Silva, PhDVP, Head of Research at Neoleukin Therapeutics
Daniel Silva is an expert in protein-folding, -structure, and -function, and is the primary architect of the Neoleukin Platform. He graduated from the National Autonomous University of Mexico and completed his initial postdoctoral training at the Hong Kong University of Science and Technology, where he developed tools to study protein-ligand binding dynamics. In 2013, Dr. Silva received a Pew Latin American postdoctoral fellowship to train with David Baker at the University of Washington, where he developed state-of-the-art de novo protein design algorithms. Dr. Silva has co-authored over 20 published research articles, including several in high profile journals such as Science and Nature. Prior to co-founding and joining Neoleukin Therapeutics, he served as a Translational Investigator in the Department of Biochemistry at the University of Washington.